MIR4729

Across TCGA pan-cancer cohorts, MIR4729 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR4729 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR4729 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4729 expression acts as an unfavorable survival marker, although some lineages such as OV and LAML show a favorable association.

COAD, KIRP, and ESCA are the cancer types where MIR4729 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	II,III,IV	0.423	0.697	.016	33	view →
KIRP	DFS	Tertile	All	0.284	0.659	<.001	30	view →
ESCA	OS	Quartile	II,III,IV	0.330	1.000	.006	26	view →
OV	OS	Tertile	II,III,IV	0.397	0.292	.019	22	view →
KICH	OS	Tertile	All	0.830	0.969	.024	9	view →
PCPG	OS	Tertile	All	0.539	0.954	.021	9	view →
LAML	DFS	Tertile	All	0.616	0.342	.034	8	view →
SARC	OS	Tertile	All	0.627	0.867	.010	6	view →
SKCM	DFS	Tertile	II,III,IV	0.568	0.243	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR4729–COAD (DFS)

Open the COAD breakdown →